A Microbiomic and Metabolomics Analysis in African Americans with Colonic Lesions Reveals Streptococcus sp. VT162 as a Marker of Neoplastic Transformation.
Microfluidics Meets Metabolomics to Reveal the Impact of Campylobacter jejuni Infection on Biochemical Pathways.